Latebreakers: FDA bill draws widespread approval

Researchers compared health care and prescription medication affordability during the COVID-19 pandemic to pre-pandemic numbers.

Don Arthur, RPh, discusses what lays ahead in independent pharmacy, from clinical care to success stories.

In a session presented at the 2024 Heart in Diabetes Conference, Matthew Weir, MD, discussed the potential benefits of GLP-1s and SGLT2 inhibitors for improved chronic kidney disease and cardiovascular outcomes.

Learn more about the ins and outs of pharmacy ownership from the experts at First Financial Bank.

Altuviiio was first granted approval by the FDA in February 2023.

A review found that many guidelines that recommended pharmacogenetic testing were inconsistent between clinical associations.